NTRR to commence Pure Plus clinical trial
The trial follows the shipment of initial test batch as well as Pure Plus from the manufacturer to a laboratory for a highly specialised Bio-energy infusion that enhnaces
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.